Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Novavax Inc NVAX

Healthcare Biotechnology
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID... see more

Recent & Breaking News (NDAQ:NVAX)

Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 10, 2015

Thomson Reuters ONE August 3, 2015

Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 10, 2015

GlobeNewswire August 3, 2015

Novavax Announces Positive Data From Phase 2 Trial of Quadrivalent Seasonal Influenza VLP

Thomson Reuters ONE July 30, 2015

Novavax Announces Positive Data From Phase 2 Trial of Quadrivalent Seasonal Influenza VLP

Thomson Reuters ONE July 30, 2015

Novavax Announces Positive Data From Phase 2 Trial of Quadrivalent Seasonal Influenza VLP

GlobeNewswire July 30, 2015

Novavax Announces Positive Data From Phase 2 Trial of Quadrivalent Seasonal Influenza VLP

GlobeNewswire July 30, 2015

Novavax Announces Positive Top-Line Data From Phase 1 Ebola Vaccine Trial on WHO Teleconference

GlobeNewswire July 21, 2015

Novavax Recognized by Washington Post as Top Workplace

GlobeNewswire June 19, 2015

Novavax Appoints Gail Boudreaux to Board

GlobeNewswire June 18, 2015

Novavax Announces Management Promotion

GlobeNewswire June 15, 2015

Novavax Reports First Quarter 2015 Financial Results

Thomson Reuters ONE May 7, 2015

Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 7, 2015

Thomson Reuters ONE April 30, 2015

Novavax to Present at the 14th Annual Needham Healthcare Conference

GlobeNewswire April 8, 2015

Novavax Announces Closing of Public Offering

Thomson Reuters ONE March 31, 2015

Novavax Announces Closing of Public Offering

GlobeNewswire March 31, 2015

Novavax Presents New Data From Non-Human Primate Ebola Challenge at the 7th International Symposium on Filoviruses

Thomson Reuters ONE March 28, 2015

Novavax Presents New Data From Non-Human Primate Ebola Challenge at the 7th International Symposium on Filoviruses

GlobeNewswire March 28, 2015

Novavax Prices Public Offering of Common Stock

Thomson Reuters ONE March 26, 2015

Novavax Prices Public Offering of Common Stock

GlobeNewswire March 26, 2015

Novavax Announces Proposed Public Offering of Common Stock

GlobeNewswire March 24, 2015